Rapport Therapeutics, Inc. RAPP
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2024-06-07
Rapport Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| D. E. Shaw & Co., Inc. | 214,831 | $9.0M | 0.45% |
| MILLENNIUM MANAGEMENT LLC | 154,908 | $6.5M | 0.32% |
| CITADEL ADVISORS LLC | 82,442 | $3.4M | 0.17% |
| AQR CAPITAL MANAGEMENT LLC | 26,454 | $1.1M | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 24,470 | $1.0M | 0.05% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.